Moderna Gets BARDA Award For $483 Mln To Speed Up COVID-19 Vaccine Development

Shares of Moderna Inc. (MRNA) are up more than 21 percent in extended trading on Thursday after the Biomedical Advanced Research and Development Authority (BARDA) committed up to $483 million to accelerate the development of the Company's mRNA vaccine candidate mRNA-1273 against the novel coronavirus.

from RTT - Biotech https://ift.tt/3agBIK4
via IFTTT